US Stock MarketDetailed Quotes

TFFP TFF Pharmaceuticals

Watchlist
  • 2.1200
  • -0.2100-9.01%
Trading Oct 15 10:40 ET
7.35MMarket Cap-308P/E (TTM)

TFF Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
95.06%650.22K
295.25%203.27K
0
0
0
333.35K
51.43K
0
0
0
Operating revenue
95.06%650.22K
295.25%203.27K
--0
--0
--0
--333.35K
--51.43K
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-13.82%4.61M
-16.02%5.99M
-31.14%21.89M
-27.26%5.37M
-39.28%4.42M
-38.85%5.35M
-14.85%7.14M
0.03%31.8M
-26.90%7.38M
-16.10%7.28M
Selling and administrative expenses
-24.19%2.02M
-21.83%2.44M
-23.41%10.57M
-29.48%2.51M
-32.12%2.27M
-27.40%2.67M
-2.92%3.12M
30.47%13.8M
11.59%3.56M
39.99%3.34M
-General and administrative expense
-24.19%2.02M
-21.83%2.44M
-23.41%10.57M
-29.48%2.51M
-32.12%2.27M
-27.40%2.67M
-2.92%3.12M
30.47%13.8M
11.59%3.56M
39.99%3.34M
Research and development costs
-3.49%2.59M
-11.52%3.56M
-34.79%12.06M
-28.09%2.97M
-40.72%2.39M
-47.44%2.68M
-23.27%4.02M
-13.17%18.5M
-40.23%4.14M
-36.50%4.03M
Other operating expenses
----
----
-48.02%-733.87K
63.45%-114.33K
-168.04%-234.76K
----
----
-462.39%-495.81K
-2,507.37%-312.78K
-75.17%-87.59K
Operating profit
21.05%-3.96M
18.28%-5.79M
31.14%-21.89M
27.26%-5.37M
39.28%-4.42M
42.66%-5.02M
15.47%-7.09M
-0.03%-31.8M
26.90%-7.38M
16.10%-7.28M
Net non-operating interest income expense
21.32%43.82K
58.92%55.75K
895.91%266.19K
1,307.46%106.18K
1,351.38%88.81K
514.29%36.12K
388.23%35.08K
-47.83%26.73K
-21.52%7.54K
-49.22%6.12K
Non-operating interest income
21.32%43.82K
58.92%55.75K
895.91%266.19K
1,307.46%106.18K
1,351.38%88.81K
514.29%36.12K
388.23%35.08K
-47.83%26.73K
-21.52%7.54K
-49.22%6.12K
Other net income (expense)
-1,397.95%-560.47K
385.24K
500.11K
-77.45K
-37.42K
Gain on sale of security
-1,397.95%-560.47K
----
--385.24K
----
----
---37.42K
----
----
----
----
Other non- operating income (expenses)
----
----
----
----
---77.45K
----
----
----
----
----
Income before tax
10.78%-4.48M
18.67%-5.74M
33.13%-21.24M
35.41%-4.76M
39.39%-4.41M
42.60%-5.02M
15.81%-7.05M
-2.36%-31.77M
26.63%-7.37M
16.18%-7.27M
Income tax
Net income
10.78%-4.48M
18.67%-5.74M
33.13%-21.24M
35.41%-4.76M
39.39%-4.41M
42.60%-5.02M
15.81%-7.05M
-2.36%-31.77M
26.63%-7.37M
16.18%-7.27M
Net income continuous Operations
10.78%-4.48M
18.67%-5.74M
33.13%-21.24M
35.41%-4.76M
39.39%-4.41M
42.60%-5.02M
15.81%-7.05M
-2.36%-31.77M
26.63%-7.37M
16.18%-7.27M
Minority interest income
Net income attributable to the parent company
10.78%-4.48M
18.67%-5.74M
33.13%-21.24M
35.41%-4.76M
39.39%-4.41M
42.60%-5.02M
15.81%-7.05M
-2.36%-31.77M
26.63%-7.37M
16.18%-7.27M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
10.78%-4.48M
18.67%-5.74M
33.13%-21.24M
35.41%-4.76M
39.39%-4.41M
42.60%-5.02M
15.81%-7.05M
-2.36%-31.77M
26.63%-7.37M
16.18%-7.27M
Basic earnings per share
64.84%-1.22
50.72%-2.4
55.27%-11.85
35.74%-1.6
68.97%-2.25
59.18%-3.47
40.97%-4.87
15.23%-26.49
75.10%-2.49
14.71%-7.25
Diluted earnings per share
64.84%-1.22
50.72%-2.4
55.27%-11.85
35.74%-1.6
68.97%-2.25
59.18%-3.47
40.97%-4.87
15.23%-26.49
75.10%-2.49
14.71%-7.25
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 95.06%650.22K295.25%203.27K000333.35K51.43K000
Operating revenue 95.06%650.22K295.25%203.27K--0--0--0--333.35K--51.43K--0--0--0
Cost of revenue
Gross profit
Operating expense -13.82%4.61M-16.02%5.99M-31.14%21.89M-27.26%5.37M-39.28%4.42M-38.85%5.35M-14.85%7.14M0.03%31.8M-26.90%7.38M-16.10%7.28M
Selling and administrative expenses -24.19%2.02M-21.83%2.44M-23.41%10.57M-29.48%2.51M-32.12%2.27M-27.40%2.67M-2.92%3.12M30.47%13.8M11.59%3.56M39.99%3.34M
-General and administrative expense -24.19%2.02M-21.83%2.44M-23.41%10.57M-29.48%2.51M-32.12%2.27M-27.40%2.67M-2.92%3.12M30.47%13.8M11.59%3.56M39.99%3.34M
Research and development costs -3.49%2.59M-11.52%3.56M-34.79%12.06M-28.09%2.97M-40.72%2.39M-47.44%2.68M-23.27%4.02M-13.17%18.5M-40.23%4.14M-36.50%4.03M
Other operating expenses ---------48.02%-733.87K63.45%-114.33K-168.04%-234.76K---------462.39%-495.81K-2,507.37%-312.78K-75.17%-87.59K
Operating profit 21.05%-3.96M18.28%-5.79M31.14%-21.89M27.26%-5.37M39.28%-4.42M42.66%-5.02M15.47%-7.09M-0.03%-31.8M26.90%-7.38M16.10%-7.28M
Net non-operating interest income expense 21.32%43.82K58.92%55.75K895.91%266.19K1,307.46%106.18K1,351.38%88.81K514.29%36.12K388.23%35.08K-47.83%26.73K-21.52%7.54K-49.22%6.12K
Non-operating interest income 21.32%43.82K58.92%55.75K895.91%266.19K1,307.46%106.18K1,351.38%88.81K514.29%36.12K388.23%35.08K-47.83%26.73K-21.52%7.54K-49.22%6.12K
Other net income (expense) -1,397.95%-560.47K385.24K500.11K-77.45K-37.42K
Gain on sale of security -1,397.95%-560.47K------385.24K-----------37.42K----------------
Other non- operating income (expenses) -------------------77.45K--------------------
Income before tax 10.78%-4.48M18.67%-5.74M33.13%-21.24M35.41%-4.76M39.39%-4.41M42.60%-5.02M15.81%-7.05M-2.36%-31.77M26.63%-7.37M16.18%-7.27M
Income tax
Net income 10.78%-4.48M18.67%-5.74M33.13%-21.24M35.41%-4.76M39.39%-4.41M42.60%-5.02M15.81%-7.05M-2.36%-31.77M26.63%-7.37M16.18%-7.27M
Net income continuous Operations 10.78%-4.48M18.67%-5.74M33.13%-21.24M35.41%-4.76M39.39%-4.41M42.60%-5.02M15.81%-7.05M-2.36%-31.77M26.63%-7.37M16.18%-7.27M
Minority interest income
Net income attributable to the parent company 10.78%-4.48M18.67%-5.74M33.13%-21.24M35.41%-4.76M39.39%-4.41M42.60%-5.02M15.81%-7.05M-2.36%-31.77M26.63%-7.37M16.18%-7.27M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 10.78%-4.48M18.67%-5.74M33.13%-21.24M35.41%-4.76M39.39%-4.41M42.60%-5.02M15.81%-7.05M-2.36%-31.77M26.63%-7.37M16.18%-7.27M
Basic earnings per share 64.84%-1.2250.72%-2.455.27%-11.8535.74%-1.668.97%-2.2559.18%-3.4740.97%-4.8715.23%-26.4975.10%-2.4914.71%-7.25
Diluted earnings per share 64.84%-1.2250.72%-2.455.27%-11.8535.74%-1.668.97%-2.2559.18%-3.4740.97%-4.8715.23%-26.4975.10%-2.4914.71%-7.25
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data